Search Results 1801-1810 of 21492 for platelets

1. Trial Of The F2 Filter And Delivery System For Embolic Protection During TAVR - Mayo Clinic

   * Patient is contraindicated for anti-platelet and/or anticoagulant therapy. * Patient refuses blood transfusion. * Renal insufficiency (creatinine \> 2.5 ...

2. Pasireotide LAR in Severe Polycystic Liver Disease - Mayo Clinic

   Platelets ≥ 100 x 109/L; Hb ≥ 9 g/dL. No evidence of significant liver disease: Serum bilirubin ≤1.5 x ULN; INR < 1.3; ALT and AST ≤ 2 x ULN. Estimated ...

3. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

   ... platelet concentration <100,000/mm3, hemoglobin <9g/dL. Clinically evident congestive heart failure (CHF) > class II of the New York Heart Association (NYHA) ...

4. From lift off to splash down: An update on Mayo Clinic stem cells in space

   ... platelets) appeared to grow much faster in space than on Earth. We also observed significant changes in gene expression as a result of exposure to ...

5. Center for Aesthetic Medicine & Surgery in Rochester - Tests and procedures - Mayo Clinic

   Platelet rich plasma therapy; Rhinoplasty; Scar revision; Sclerotherapy; Skin lesion removal; Skin resurfacing; Skin surgery; Spider vein removal; Stem cell ...

6. Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults (BRIO) - Mayo Clinic

   Current anti-coagulant or anti-platelet therapy (Coumadin, Eliquis, Pradaxa, Xarelto, heparin, Lovenox, Plavix); Clinically significant abnormality in any of ...

7. A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System

   Uncorrected thrombocytopenia or generalized coagulopathy (e.g., platelet count < 75,000, INR > 2.0 or PTT > 2.5 times control in the absence of anticoagulation ...

8. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

   Platelet count ≥ 100,000/ul; White blood cell count (WBC) ≥ 3,000/ul; Alanine aminotransferase (ALT) ≤ 2 x institutional upper limit of normal (ULN) ...

9. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Platelet count >= 75,000/uL (transfusion independent); Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or ...

10. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

    Platelet count ≥ 100,000/mm3; Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with creatinine clearance ≥ 50 mL/min using the ...